Viewing Study NCT00280956


Ignite Creation Date: 2025-12-24 @ 11:35 PM
Ignite Modification Date: 2026-04-05 @ 8:53 AM
Study NCT ID: NCT00280956
Status: COMPLETED
Last Update Posted: 2016-06-16
First Post: 2006-01-21
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Open Label Natalizumab Safety Extension Study for Subjects With Crohn's Disease
Sponsor: Biogen
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module